OUR PRODUCTS

MOBILE APPS

GENERAL INFO

KOD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Kodiak Sciences (KOD) Ownership - Who owns Kodiak Sciences?

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

1200 Page Mill Road

Phone

+1 650 281-0850

Employees

111

Web

https://www.kodiak.com

Details

Group

Domestic Stock Funds

Fundamentals

KOD

Capitalization

500M

P/E Ratio

N/A

Risk (Beta)

2.52

Dividend Yield

N/A

Total Cash

104M

Total Cash/Share

1.97

Total Debt

65.2M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

70.3M

P/B Ratio

7.12

Cash Flow

N/A

Earnings

-3.79

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

3.48

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-170.11M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-60.71

Shares Held By Institutions

161M

Shares Outstanding - Current

52.8M

Total Liabilities

186M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-4.824

View a ticker or compare two or three

Compare

KOD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For KOD
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KOD showed earnings on August 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of novel therapies for the treatment of retinal disease

Industry Biotechnology